4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-094123
Chief Development Officer sold 100 shares at $73.51 ($7,351)
- Chief Development Officer acquired 100 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +100 | $21.65 | $2,165 | 5,587 | D |
| 2025-07-01 | Sale : show line 2 in the form 10b5-1 | −100 | $73.51 | $7,351 | 5,487 | D |
| Open-market sales · 100 sh · avg $73.51 · $7,351 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) | −100 | 389,900 | D |
Loading xslF345X05/ownership.xml…